View in EDS

Bimodal silencing of the acinar cell-specific mRNA translation repressor PAIP2B defines a poor prognostic subgroup within the classical pancreatic tumor type.

Saved in:
Bibliographic Details
Title: Bimodal silencing of the acinar cell-specific mRNA translation repressor PAIP2B defines a poor prognostic subgroup within the classical pancreatic tumor type.
Authors: Corre E; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire D'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire Du Cancer, 31037, Toulouse, France. Electronic address: corre.eulalie@gmail.com., Alard A; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire D'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire Du Cancer, 31037, Toulouse, France. Electronic address: amandine.alard@evotec.com., Marbœuf C; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire D'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire Du Cancer, 31037, Toulouse, France. Electronic address: tedwane.cm@gmail.com., Lasfargues C; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire D'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire Du Cancer, 31037, Toulouse, France. Electronic address: charline.lasfargues@univ-tlse3.fr., Dailhau S; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire D'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire Du Cancer, 31037, Toulouse, France. Electronic address: sandra.dailhau@inserm.fr., Blum Y; Univ Rennes, CNRS, INSERM, IGDR (Institut de Génétique et Développement de Rennes), UMR-6290, ERL-U1305, 35000, Rennes, France. Electronic address: yuna.blum@univ-rennes1.fr., Nicolle R; Univ Paris Cité, CNRS, INSERM, CRI (Centre de Recherche sur L'Inflammation), UMR-1149, ERL-8252, 75018, Paris, France. Electronic address: remy.nicolle@inserm.fr., Iovanna J; Univ Aix-Marseille, CNRS, INSERM, CRCM (Cancer Research Center of Marseille, UMR-1068, UMR-7258, Institut Paoli-Calmettes, 13288, Marseille, France. Electronic address: juan.iovanna@inserm.fr., Dusetti N; Univ Aix-Marseille, CNRS, INSERM, CRCM (Cancer Research Center of Marseille, UMR-1068, UMR-7258, Institut Paoli-Calmettes, 13288, Marseille, France. Electronic address: nelson.dusetti@inserm.fr., Pyronnet S; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire D'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire Du Cancer, 31037, Toulouse, France. Electronic address: stephane.pyronnet@inserm.fr.
Source: Cancer letters [Cancer Lett] 2025 Nov 01; Vol. 632, pp. 217971. Date of Electronic Publication: 2025 Aug 09.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1872-7980
DOI:10.1016/j.canlet.2025.217971